Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1260

1.

[Characterization and Analytical Techniques for Nano-DDS Formulations].

Ishihara H, Sakai-Kato K.

Yakugaku Zasshi. 2019;139(2):235-236. doi: 10.1248/yakushi.18-00171-F. Japanese. No abstract available.

2.

β-Hydroxy-β-methyl Butyrate/L-Arginine/L-Glutamine Supplementation for Preventing Hand-Foot Skin Reaction in Sorafenib for Advanced Hepatocellular Carcinoma.

Naganuma A, Hoshino T, Ohno N, Ogawa Y, Murakami T, Horiguchi S, Uehara D, Suzuki Y, Hatanaka T, Kudo T, Ishihara H, Sato K, Kakizaki S, Takagi H.

In Vivo. 2019 Jan-Feb;33(1):155-161. doi: 10.21873/invivo.11452.

PMID:
30587616
3.

Kinetics of cytokine mRNA and protein expression by plastic adherent cells in the thymus after split-dose irradiation.

Nagayasu A, Kakinuma S, Nishimura M, Shang Y, Sunaoshi M, Tsuruoka C, Ishihara H, Shimada Y, Kobayashi Y.

Cytokine. 2018 Nov 19. pii: S1043-4666(18)30418-6. doi: 10.1016/j.cyto.2018.11.006. [Epub ahead of print]

PMID:
30467095
4.

Elsberg syndrome related to varicella zoster virus infection with painless skin lesions in an elderly woman with poorly controlled type 2 diabetes mellitus.

Saito H, Ebashi M, Kushimoto M, Ikeda J, Egashira F, Yamaguchi S, Watanabe K, Ogawa K, Suzuki Y, Ishihara H, Fujishiro M.

Ther Clin Risk Manag. 2018 Oct 9;14:1951-1954. doi: 10.2147/TCRM.S178782. eCollection 2018.

5.

Cilostazol decreases duration of spreading depolarization and spreading ischemia after aneurysmal subarachnoid hemorrhage.

Sugimoto K, Nomura S, Shirao S, Inoue T, Ishihara H, Kawano R, Kawano A, Oka F, Suehiro E, Sadahiro H, Shinoyama M, Oku T, Maruta Y, Hirayama Y, Hiyoshi K, Kiyohira M, Yoneda H, Okazaki K, Dreier JP, Suzuki M.

Ann Neurol. 2018 Dec;84(6):873-885. doi: 10.1002/ana.25361. Epub 2018 Nov 29.

PMID:
30341966
6.

Effect of Changes in Skeletal Muscle Mass on Oncological Outcomes During First-Line Sunitinib Therapy for Metastatic Renal Cell Carcinoma.

Ishihara H, Takagi T, Kondo T, Fukuda H, Yoshida K, Iizuka J, Tanabe K.

Target Oncol. 2018 Dec;13(6):745-755. doi: 10.1007/s11523-018-0600-3.

PMID:
30328067
7.

Cerebral infarction associated with benign mucin-producing adenomyosis: report of two cases.

Okazaki K, Oka F, Ishihara H, Suzuki M.

BMC Neurol. 2018 Oct 4;18(1):166. doi: 10.1186/s12883-018-1169-2.

8.

Immediate Progressive Disease in Patients with Metastatic Renal Cell Carcinoma Treated with Nivolumab: a Multi-Institution Retrospective Study.

Ishihara H, Kondo T, Takagi T, Tachibana H, Fukuda H, Yoshida K, Iizuka J, Kobayashi H, Tanabe K.

Target Oncol. 2018 Oct;13(5):611-619. doi: 10.1007/s11523-018-0591-0.

PMID:
30232691
9.

DNA methylation marker to estimate the breast cancer cell fraction in DNA samples.

Ishihara H, Yamashita S, Fujii S, Tanabe K, Mukai H, Ushijima T.

Med Oncol. 2018 Sep 14;35(11):147. doi: 10.1007/s12032-018-1207-3.

PMID:
30218172
10.

Acquired cystic disease-associated renal cell carcinoma is the most common subtype in long-term dialyzed patients: Central pathology results according to the 2016 WHO classification in a multi-institutional study.

Kondo T, Sasa N, Yamada H, Takagi T, Iizuka J, Kobayashi H, Yoshida K, Fukuda H, Ishihara H, Tanabe K, Tsuzuki T.

Pathol Int. 2018 Oct;68(10):543-549. doi: 10.1111/pin.12718. Epub 2018 Sep 6.

PMID:
30187581
11.

Pancreatic Cancer Cell Fraction Estimation in a DNA Sample.

Ishihara H, Yamashita S, Amano R, Kimura K, Hirakawa K, Ueda T, Murakami Y, Tamori A, Tanabe K, Kawada N, Hagihara A, Ushijima T.

Oncology. 2018;95(6):370-379. doi: 10.1159/000491637. Epub 2018 Aug 27.

PMID:
30149376
12.

Rationale and Design of the STOP-OB Study for Evaluating the Effects of Tofogliflozin and Glimepiride on Fat Deposition in Type 2 Diabetes Patients Treated with Metformin/DPP-4 Inhibitor Dual Therapy.

Ishihara H, Anai M, Seino H, Kitazawa T, Ohashi H, Ai M, Inoue M, Fujishiro M, Inazawa T, Kuroda H, Yamada M.

Diabetes Ther. 2018 Oct;9(5):2117-2125. doi: 10.1007/s13300-018-0491-4. Epub 2018 Aug 25.

13.

Impact of the Mayo Adhesive Probability Score on the Complexity of Robot-Assisted Partial Nephrectomy.

Ishiyama R, Kondo T, Takagi T, Iizuka J, Kobayashi H, Omae K, Fukuda H, Ishihara H, Tanabe K.

J Endourol. 2018 Oct;32(10):928-933. doi: 10.1089/end.2017.0779. Epub 2018 Sep 25.

PMID:
30141346
14.

Durable response after discontinuation of nivolumab therapy in patients with metastatic renal cell carcinoma.

Takagi T, Yoshida K, Kobayashi H, Kondo T, Iizuka J, Okumi M, Ishida H, Fukuda H, Ishihara H, Tanabe K.

Jpn J Clin Oncol. 2018 Sep 1;48(9):860-863. doi: 10.1093/jjco/hyy106.

PMID:
30113653
15.

Risk factors for severity of colonic diverticular hemorrhage.

Kinjo K, Matsui T, Hisabe T, Ishihara H, Kojima T, Chuman K, Yasukawa S, Beppu T, Koga A, Ishikawa S, Kishi M, Takatsu N, Hirai F, Yao K, Ueki T, Washio M.

Intest Res. 2018 Jul;16(3):458-466. doi: 10.5217/ir.2018.16.3.458. Epub 2018 Jul 27.

16.

Development of a powered variable-stiffness exoskeleton device for elbow rehabilitation.

Liu Y, Guo S, Hirata H, Ishihara H, Tamiya T.

Biomed Microdevices. 2018 Aug 3;20(3):64. doi: 10.1007/s10544-018-0312-6.

PMID:
30074095
17.

Thrombolysis with rt-PA under Rivaroxaban Anticoagulation in a Hypertensive Rat Model of Intraluminal Middle Cerebral Artery Occlusion.

Izuma H, Oka F, Ishihara H, Inoue T, Suehiro E, Nomura S, Suzuki M.

J Stroke Cerebrovasc Dis. 2018 Oct;27(10):2761-2767. doi: 10.1016/j.jstrokecerebrovasdis.2018.06.003. Epub 2018 Jul 25.

PMID:
30056000
18.

Glottic cancer in patients without complaints of hoarseness.

Tachibana T, Orita Y, Marunaka H, Makihara S, Hirai M, Miki K, Ogawara Y, Ishihara H, Matsuyama Y, Abe-Fujisawa I, Shimizu A, Sato Y, Nishizaki K.

Head Neck. 2018 Jul;40(7):1608. doi: 10.1002/hed.25196. Epub 2018 Mar 31. No abstract available.

PMID:
29984522
19.

A case of drug induced lung injury caused by levofloxacin eye drops.

Hosogaya N, Toida K, Ishihara H, Kugiyama K.

Respir Med Case Rep. 2018 Mar 16;24:12-15. doi: 10.1016/j.rmcr.2018.03.010. eCollection 2018.

20.

Ipragliflozin Add-on Therapy to a GLP-1 Receptor Agonist in Japanese Patients with Type 2 Diabetes (AGATE): A 52-Week Open-Label Study.

Ishihara H, Yamaguchi S, Nakao I, Sakatani T.

Diabetes Ther. 2018 Aug;9(4):1549-1567. doi: 10.1007/s13300-018-0455-8. Epub 2018 Jun 20.

21.

Performance evaluation of a robot-assisted catheter operating system with haptic feedback.

Song Y, Guo S, Yin X, Zhang L, Hirata H, Ishihara H, Tamiya T.

Biomed Microdevices. 2018 Jun 20;20(2):50. doi: 10.1007/s10544-018-0294-4.

PMID:
29926195
22.

Decreased relative dose intensity during the early phase of treatment impacts the therapeutic efficacy of sunitinib in metastatic renal cell carcinoma.

Ishihara H, Takagi T, Kondo T, Iwamoto K, Tachibana H, Yoshida K, Omae K, Iizuka J, Kobayashi H, Tanabe K.

Jpn J Clin Oncol. 2018 Jul 1;48(7):667-672. doi: 10.1093/jjco/hyy078.

PMID:
29860353
23.

Prognostic Impact of the Components of Progressive Disease on Survival After First-Line Tyrosine Kinase Inhibitor Therapy for Metastatic Renal Cell Carcinoma.

Ikeda T, Ishihara H, Takagi T, Kondo T, Yoshida K, Iizuka J, Tanabe K.

Target Oncol. 2018 Jun;13(3):379-387. doi: 10.1007/s11523-018-0569-y.

PMID:
29785576
24.

Peri-stent contrast staining post-everolimus eluting stent deployment disappeared in a very short duration.

Maeda T, Teramoto T, Tanaka N, Ishihara H, Teramura M, Ichihashi K.

Cardiovasc Interv Ther. 2018 May 11. doi: 10.1007/s12928-018-0528-7. [Epub ahead of print] No abstract available.

PMID:
29752590
25.

A randomized, double-blind, placebo-controlled Phase III trial of duloxetine in Japanese patients with knee pain due to osteoarthritis.

Uchio Y, Enomoto H, Alev L, Kato Y, Ishihara H, Tsuji T, Ochiai T, Konno S.

J Pain Res. 2018 Apr 18;11:809-821. doi: 10.2147/JPR.S164128. eCollection 2018.

26.

Evaluation of relative dose intensity during the early phase of first-line sunitinib treatment using a 2-week-on/1-week-off regimen for metastatic renal cell carcinoma.

Iwamoto K, Ishihara H, Takagi T, Kondo T, Yoshida K, Iizuka J, Tanabe K.

Med Oncol. 2018 Apr 23;35(6):78. doi: 10.1007/s12032-018-1139-y.

PMID:
29687160
27.

Idiopathic basal ganglia calcification associated with cerebral micro-infarcts: a case report.

Nishimoto T, Oka F, Ishihara H, Shinoyama M, Suzuki M.

BMC Neurol. 2018 Apr 17;18(1):42. doi: 10.1186/s12883-018-1048-x.

28.

Obesity does not affect peri- and postoperative outcomes of transabdominal laparoscopic adrenalectomy.

Inaishi T, Kikumori T, Takeuchi D, Ishihara H, Miyajima N, Shibata M, Takano Y, Nakanishi K, Noda S, Kodera Y.

Nagoya J Med Sci. 2018 Feb;80(1):21-28. doi: 10.18999/nagjms.80.1.21.

29.

Simulation of Stimuli-Responsive and Stoichiometrically Controlled Release Rate of Doxorubicin from Liposomes in Tumor Interstitial Fluid.

Yamamoto E, Hyodo K, Suzuki T, Ishihara H, Kikuchi H, Kato M.

Pharm Res. 2018 Mar 19;35(5):103. doi: 10.1007/s11095-018-2380-y.

PMID:
29557075
30.

Design and performance evaluation of collision protection-based safety operation for a haptic robot-assisted catheter operating system.

Zhang L, Guo S, Yu H, Song Y, Tamiya T, Hirata H, Ishihara H.

Biomed Microdevices. 2018 Feb 23;20(2):22. doi: 10.1007/s10544-018-0266-8.

PMID:
29476379
31.

Generation and Characterization of a Novel Small Biologic Alternative to Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Antibodies, DS-9001a, Albumin Binding Domain-Fused Anticalin Protein.

Masuda Y, Yamaguchi S, Suzuki C, Aburatani T, Nagano Y, Miyauchi R, Suzuki E, Yamamura N, Nagatomo K, Ishihara H, Okuno K, Nara F, Matschiner G, Hashimoto R, Takahashi T, Nishizawa T.

J Pharmacol Exp Ther. 2018 May;365(2):368-378. doi: 10.1124/jpet.117.246652. Epub 2018 Feb 20.

PMID:
29463608
32.

Mexican-Hat-Like Response in a Flexible Tactile Sensor Using a Magnetorheological Elastomer.

Kawasetsu T, Horii T, Ishihara H, Asada M.

Sensors (Basel). 2018 Feb 14;18(2). pii: E587. doi: 10.3390/s18020587.

33.

Validity of conventional endoscopy using "non-extension sign" for optical diagnosis of colorectal deep submucosal invasive cancer.

Hisabe T, Tsuda S, Hoashi T, Ishihara H, Yamasaki K, Yasaka T, Hirai F, Matsui T, Yao K, Tanabe H, Iwashita A.

Endosc Int Open. 2018 Feb;6(2):E156-E164. doi: 10.1055/s-0043-121881. Epub 2018 Feb 1.

34.

Efficacy and safety of third-line molecular-targeted therapy in metastatic renal cell carcinoma resistant to first-line vascular endothelial growth factor receptor tyrosine kinase inhibitor and second-line therapy.

Ishihara H, Takagi T, Kondo T, Tachibana H, Yoshida K, Omae K, Iizuka J, Kobayashi H, Tanabe K.

Int J Clin Oncol. 2018 Jun;23(3):559-567. doi: 10.1007/s10147-018-1241-3. Epub 2018 Jan 11.

PMID:
29327159
35.

[Effect of Platelet Concentrate Transfusion on Prognosis of Patients with Intracerebral Hemorrhage Treated with Anti-Platelet Agents].

Sugimoto K, Ishihara H, Shinoyama M, Sadahiro H, Suzuki M.

No Shinkei Geka. 2017 Nov;45(11):965-970. doi: 10.11477/mf.1436203629. Japanese.

PMID:
29172201
36.

Evaluation of renal function change during first-line tyrosine kinase inhibitor therapy for metastatic renal cell carcinoma.

Ishihara H, Kondo T, Fukuda H, Yoshida K, Omae K, Takagi T, Iizuka J, Kobayashi H, Tanabe K.

Jpn J Clin Oncol. 2017 Dec 1;47(12):1175-1181. doi: 10.1093/jjco/hyx161.

37.

[Usefulness of Bilateral rSO<sub>2</sub> Monitoring for Predicting Cerebral Hyperperfusion Syndrome after Carotid Artery Stenting].

Niimi J, Ishihara S, Tsukagoshi E, Neki H, Kakehi Y, Uemiya N, Mizokami K, Ishihara H, Kohyama S, Yamane F.

No Shinkei Geka. 2017 Oct;45(10):859-867. doi: 10.11477/mf.1436203608. Japanese.

PMID:
29046465
38.

Trk-fused gene (TFG) regulates pancreatic β cell mass and insulin secretory activity.

Yamamotoya T, Nakatsu Y, Kushiyama A, Matsunaga Y, Ueda K, Inoue Y, Inoue MK, Sakoda H, Fujishiro M, Ono H, Kiyonari H, Ishihara H, Asano T.

Sci Rep. 2017 Oct 12;7(1):13026. doi: 10.1038/s41598-017-13432-x.

39.

The Author Replies.

Miyo M, Takemasa I, Ishihara H, Hata T, Mizushima T, Ohno Y, Doki Y, Mori M.

Dis Colon Rectum. 2017 Nov;60(11):e631-e632. doi: 10.1097/DCR.0000000000000938. No abstract available.

PMID:
28991091
40.

Derivation of simple rules for complex flow vector fields on the lower part of the human face for robot face design.

Ishihara H, Ota N, Asada M.

Bioinspir Biomim. 2017 Nov 27;13(1):015002. doi: 10.1088/1748-3190/aa8f33.

PMID:
28949300
41.

Safety and Time Course of Drip-and-Ship in Treatment of Acute Ischemic Stroke.

Ishihara H, Oka F, Oku T, Shinoyama M, Suehiro E, Sugimoto K, Suzuki M.

J Stroke Cerebrovasc Dis. 2017 Nov;26(11):2477-2481. doi: 10.1016/j.jstrokecerebrovasdis.2017.03.008. Epub 2017 Sep 19.

PMID:
28935501
42.

Enhanced Plasmonic Wavelength Selective Infrared Emission Combined with Microheater.

Ishihara H, Masuno K, Ishii M, Kumagai S, Sasaki M.

Materials (Basel). 2017 Sep 14;10(9). pii: E1085. doi: 10.3390/ma10091085.

43.

Severe Hypertriglyceridemia Possibly Masked Acute Pancreatitis and Led to a Difficult Diagnosis in an Obese Patient with Ketoacidosis-onset Type 2 Diabetes.

Fujishiro M, Horita A, Nakagawara H, Mawatari T, Kishigami Y, Tominaga Y, Moriyama M, Ishihara H.

Intern Med. 2017 Oct 1;56(19):2611-2616. doi: 10.2169/internalmedicine.8474-16. Epub 2017 Sep 6.

44.

Association between Skeletal Muscle Depletion and Sorafenib Treatment in Male Patients with Hepatocellular Carcinoma: A Retrospective Cohort Study.

Naganuma A, Hoshino T, Suzuki Y, Uehara D, Kudo T, Ishihara H, Sato K, Kakizaki S, Yamada M, Takagi H.

Acta Med Okayama. 2017 Aug;71(4):291-299. doi: 10.18926/AMO/55305.

45.

Total Clinical Course and Autopsy Findings of Left Ventricular Outflow Tract Obstruction Due to Sigmoid Septum: Histologically Proven Isolated Basal Septal Hypertrophy.

Kawai K, Sengoku H, Ishihara H, Akematsu T, Nanahoshi M, Hariki H, Hasokawa M, Hirata KI, Yamabe H.

Intern Med. 2017 Aug 15;56(16):2151-2154. doi: 10.2169/internalmedicine.8247-16. Epub 2017 Aug 1.

46.

Successful endovascular treatment for thrombosed giant aneurysm of the V1 segment of the vertebral artery: A case report.

Kiyohira M, Ishihara H, Oku T, Kawano A, Oka F, Suzuki M.

Interv Neuroradiol. 2017 Dec;23(6):628-631. doi: 10.1177/1591019917722515. Epub 2017 Jul 27.

47.

Primary Central Nervous System Post-Transplant Lymphoproliferative Disorder Following Kidney Transplantation: A Multi-Institution Study in Japan Over 30 years.

Ishihara H, Okumi M, Tanabe K; Japan Academic Consortium of Kidney Transplantation (JACK).

Ther Apher Dial. 2017 Oct;21(5):516-518. doi: 10.1111/1744-9987.12568. Epub 2017 Jul 17. No abstract available.

PMID:
28714124
48.

Leaf Starch Turnover Occurs in Long Days and in Falling Light at the End of the Day.

Fernandez O, Ishihara H, George GM, Mengin V, Flis A, Sumner D, Arrivault S, Feil R, Lunn JE, Zeeman SC, Smith AM, Stitt M.

Plant Physiol. 2017 Aug;174(4):2199-2212. doi: 10.1104/pp.17.00601. Epub 2017 Jun 29.

49.

Effect of ABO blood type on the outcomes of patients with metastatic renal cell carcinoma treated with first-line tyrosine kinase inhibitors.

Omae K, Fukuma S, Ikenoue T, Kondo T, Takagi T, Ishihara H, Tanabe K, Fukuhara S.

Urol Oncol. 2017 Sep;35(9):540.e7-540.e12. doi: 10.1016/j.urolonc.2017.04.004. Epub 2017 Jun 16.

PMID:
28624136
50.

Time to progression after first-line tyrosine kinase inhibitor predicts survival in patients with metastatic renal cell carcinoma receiving second-line molecular-targeted therapy.

Ishihara H, Kondo T, Yoshida K, Omae K, Takagi T, Iizuka J, Tanabe K.

Urol Oncol. 2017 Sep;35(9):542.e1-542.e9. doi: 10.1016/j.urolonc.2017.05.014. Epub 2017 Jun 12.

PMID:
28619633

Supplemental Content

Loading ...
Support Center